These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8058744)
21. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain. Yu FH; Huang KJ; Wang CT J Virol; 2017 May; 91(10):. PubMed ID: 28250114 [TBL] [Abstract][Full Text] [Related]
22. In vitro refolding of cyclomaltodextrin glucanotransferase from cytoplasmic inclusion bodies formed upon expression in Escherichia coli. Hellman J; Lassila P; Mäntsälä P Protein Expr Purif; 1995 Feb; 6(1):56-62. PubMed ID: 7756839 [TBL] [Abstract][Full Text] [Related]
23. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity. Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662 [TBL] [Abstract][Full Text] [Related]
24. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Park J; Morrow CD Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189 [TBL] [Abstract][Full Text] [Related]
25. Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles. Adamson CS; Nermut M; Jones IM Virology; 2003 Mar; 308(1):157-65. PubMed ID: 12706099 [TBL] [Abstract][Full Text] [Related]
26. Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. Paulus C; Hellebrand S; Tessmer U; Wolf H; Kräusslich HG; Wagner R J Biol Chem; 1999 Jul; 274(31):21539-43. PubMed ID: 10419458 [TBL] [Abstract][Full Text] [Related]
27. Proteolytic activity in vivo and encapsidation of recombinant human immunodeficiency virus type 1 proteinase expressed in baculovirus-infected cells. Royer M; Bardy M; Gay B; Tournier J; Boulanger P J Gen Virol; 1997 Jan; 78 ( Pt 1)():131-42. PubMed ID: 9010296 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin. Chen GQ; Gouaux JE Protein Sci; 1996 Mar; 5(3):456-67. PubMed ID: 8868482 [TBL] [Abstract][Full Text] [Related]
30. Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6. Beissinger M; Paulus C; Bayer P; Wolf H; Rösch P; Wagner R Eur J Biochem; 1996 Apr; 237(2):383-92. PubMed ID: 8647076 [TBL] [Abstract][Full Text] [Related]
31. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease. Agniswamy J; Sayer JM; Weber IT; Louis JM Biochemistry; 2012 Feb; 51(5):1041-50. PubMed ID: 22242794 [TBL] [Abstract][Full Text] [Related]
32. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1. Paulus C; Ludwig C; Wagner R Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852 [TBL] [Abstract][Full Text] [Related]
33. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406 [TBL] [Abstract][Full Text] [Related]
34. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme. Martinez A; Knappskog PM; Olafsdottir S; Døskeland AP; Eiken HG; Svebak RM; Bozzini M; Apold J; Flatmark T Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):589-97. PubMed ID: 7887915 [TBL] [Abstract][Full Text] [Related]
35. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357 [TBL] [Abstract][Full Text] [Related]
36. Thermodynamics of maltose binding protein unfolding. Novokhatny V; Ingham K Protein Sci; 1997 Jan; 6(1):141-6. PubMed ID: 9007986 [TBL] [Abstract][Full Text] [Related]
38. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates. Pettit SC; Lindquist JN; Kaplan AH; Swanstrom R Retrovirology; 2005 Nov; 2():66. PubMed ID: 16262906 [TBL] [Abstract][Full Text] [Related]
39. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity. Yu FH; Wang CT Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366 [TBL] [Abstract][Full Text] [Related]
40. Identification of a topology control domain in the tetracycline resistance protein. Miller KW; Jewell JE Arch Biochem Biophys; 1995 Oct; 322(2):445-52. PubMed ID: 7574720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]